Company Information

1. Name

Biosolution Co., Ltd.

2. Website Address

http://www.biosolutions.co.kr

3. Location

5F, Seoul Technopark, 232, Gongneung-ro, Nowon-gu, Seoul 01811, Korea

4. Contacts

TEL : +82-2-3446-8884 FAX : +82-2-3445-1380

Email : dvmljs@biosolutions.co.kr

Pharmaceutical Product Information

1. Brand Name

KeraHeal®

2. Active Ingredient

Autologous skin-derived keratinocytes

3. Indication

1. Deep 2nd degree burns that cover more than 30% of TBSA

2. 3rd degree burns that cover more than 10% of TBSA

4. Information

KeraHeal® is a spray-type autologous keratinocyte therapy product that has received product approval in 2006 by the MFDS.

Keratinocytes are separated and cultured from the patient’s normal skin, which then form a new epidermal layer on the wound through engraftment and duplication.

KeraHeal® is composed of keratinocytes that cultivate, but do not differentiate which in turn shows a high take rate.

5. Images

Pharmaceutical Product Information

1. Brand Name

KeraHeal-Allo™

2. Active Ingredient

Allogeneic skin-derived keratinocytes

3. Indication

Deep second degree burns

4. Information

KeraHeal-Allo™ is a hydrogel-type allogeneic keratinocyte therapy product that has received product approval in 2015 by the MFDS.

KeraHeal-Allo™ is composed of allogeneic keratinocytes that promote re-epithelialization by secreting growth factors and cytokines to stimulate the cells around the wound.

Keratinocytes are suspended in a thermosensitive hydrogel which transforms into gel from liquid when in contact with body temperature.

KeraHeal-Allo™ can be stored at –20℃ for up to 18 months.

5. Images